References
- Dalby R, Suman J. Inhalation therapy: technological milestones in asthma treatment. Adv Drug Deliv Rev 2003;55:779–791.
- Newman SP, Clarke SW. Aerosol in medicine, principles, diagnosis and therapy. In: Moren F, Newhouse MT, Dolovich MB, ed. Elsevier, 1985, 289–312.
- Detjen PF. Allergic disease: diagnosis and management. 4th ed. In: Patterson R, Grammer LC, et al. ed. Philadelphia: Lippincott, 1993, 853–890.
- Molina M, Rolands FS. Stratospheric sink for chlorofluoromethanes: chlorine atom catalysed destruction of ozone. Nature 1974; 249, 810–812.
- Steed KP, Hooper G, Brickwell J, Newman SP. The oropharyngeal and lung deposition patterns of a fusafungine MDI spray delivered by HFA 134a propellant or by CFC 12 propellant. Int J Pharm 1995; 123, 291–293.
- Vervaet C, Byron PR. Drug–surfactant–propellant interactions in HFA-formulations. Int J Pharm 1999; 186, 13–30.7) Smyth HDC. The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers. Adv Drug Deliv Rev 2003; 55, 807–828.
- Smyth HDC. The influence of formulation variables on the performance of alternative propellant-driven metered dose inhalers. Adv Drug Deliv Rev 2003; 55, 807–828.
- Blondino FE, Byron PR. Surfactant dissolution and water solubilization in chlorine-free liquified gas propellants. Drug Dev Ind Pharm 1998;24:935–945.
- Keller M. Innovations and perspectives of metered dose inhalers in pulmonary drug delivery. Int J Pharm 1999;186:81–90.
- Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers. Chest 2002;122:510–516.
- Miller NC. The effect of water in inhalation suspension aerosol formulation. Eds. Byron PR. Respiratory drug delivery, Boca Raton, FL: CRC Press, 1990; pp. 249–257.
- Williams RO 3rd, Hu C. Moisture uptake and its influence on pressurized metered-dose inhalers. Pharm Dev Technol 2000;5:153–162.
- USP34, General chapter <601> Aerosols, United States Pharmacopeia 2011; 218–239.
- Murata S, Ito H, Izumi T, Chikushi A. Effect of the moisture content in aerosol on the spray performance of Stmerin D HFA preparations. Chem Pharm Bull 2006;54:1276–1280.
- Polli GP, Grim WM, Bacher FA, Yunker MH. Influence of formulation on aerosol particle size. J Pharm Sci 1969;58:484–486.
- Steckel H, Mueller BW. Metered-dose inhaler formulation of fluticasone-17-propionate micronized with supercritical carbon dioxide using the alternative propellant HFA-227. Int J Pharm 1998; 173, 25–33.